323 related articles for article (PubMed ID: 30453465)
1. Impact of Sodium
Li Y; Yang D; Zhu C
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
[TBL] [Abstract][Full Text] [Related]
2. Development and In Vitro and In Vivo Evaluation of Microspheres Containing Sodium
Li Y; Zhu C
Molecules; 2020 Apr; 25(8):. PubMed ID: 32340157
[TBL] [Abstract][Full Text] [Related]
3. Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers.
Brayden D; Creed E; O'Connell A; Leipold H; Agarwal R; Leone-Bay A
Pharm Res; 1997 Dec; 14(12):1772-9. PubMed ID: 9453067
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method.
Hess S; Rotshild V; Hoffman A
Eur J Pharm Sci; 2005 Jun; 25(2-3):307-12. PubMed ID: 15911227
[TBL] [Abstract][Full Text] [Related]
5. Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino] caprylate.
Malkov D; Wang HZ; Dinh S; Gomez-Orellana I
Pharm Res; 2002 Aug; 19(8):1180-4. PubMed ID: 12240944
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Pharmacokinetics and Systemic Effects of a Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl)amino] Caprylate in Rats.
Chiang PC; Deshmukh G; Liu J; Nagapudi K; Chen JZ; Valle N; Li R; Plise EG; Durk MR
J Pharm Sci; 2020 Aug; 109(8):2629-2636. PubMed ID: 32360544
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects.
Castelli MC; Wong DF; Friedman K; Riley MG
Clin Ther; 2011 Jul; 33(7):934-45. PubMed ID: 21722960
[TBL] [Abstract][Full Text] [Related]
8. Elucidating a Potential Mechanism of Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl) amino] Caprylate in Rats: Evidence of Lymphatic Absorption of Cyanocobalamin using the Mesenteric Lymph Duct Cannulated Rat.
Chiang PC; Liu J; Nagapudi K; Wu R; Dolton M; Chen J; Plise E; Liu L; Durk MR
J Pharm Sci; 2022 Dec; 111(12):3417-3423. PubMed ID: 36228756
[TBL] [Abstract][Full Text] [Related]
9. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative.
Alani AW; Robinson JR
Pharm Res; 2008 Jan; 25(1):48-54. PubMed ID: 17846867
[TBL] [Abstract][Full Text] [Related]
11. [Studies on gastrointestinal absorption enhancement effect and mechanism of sodium N-[8-(2-hydroxybenzyl)amino] caprylate to insulin solution].
Qi R; Ping QN; Zhao W
Yao Xue Xue Bao; 2003 Dec; 38(12):953-6. PubMed ID: 15040094
[TBL] [Abstract][Full Text] [Related]
12. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
[TBL] [Abstract][Full Text] [Related]
13. Effect of sodium caprate on the oral absorptions of danshensu and salvianolic acid B.
Zhou L; Chow MS; Zuo Z
Int J Pharm; 2009 Sep; 379(1):109-18. PubMed ID: 19555749
[TBL] [Abstract][Full Text] [Related]
14. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
[TBL] [Abstract][Full Text] [Related]
15. Oral absorption enhancement of cromolyn sodium through noncovalent complexation.
Ding X; Rath P; Angelo R; Stringfellow T; Flanders E; Dinh S; Gomez-Orellana I; Robinson JR
Pharm Res; 2004 Dec; 21(12):2196-206. PubMed ID: 15648250
[TBL] [Abstract][Full Text] [Related]
16. Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl)amino]octanoate (SNAC).
Mortensen JS; Bohr SS; Harloff-Helleberg S; Hatzakis NS; Saaby L; Nielsen HM
J Control Release; 2022 Dec; 352():163-178. PubMed ID: 36314534
[TBL] [Abstract][Full Text] [Related]
17. Influence of Bile Composition on Membrane Incorporation of Transient Permeability Enhancers.
Hossain S; Joyce P; Parrow A; Jõemetsa S; Höök F; Larsson P; Bergström CAS
Mol Pharm; 2020 Nov; 17(11):4226-4240. PubMed ID: 32960068
[TBL] [Abstract][Full Text] [Related]
18. Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration.
Granhall C; Bækdal TA; Breitschaft A; Søndergaard FL; Anderson TW; Thomsen M
Diabetes Ther; 2021 Sep; 12(9):2599-2610. PubMed ID: 34319564
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
[TBL] [Abstract][Full Text] [Related]
20. Improved oral bioavailability of notoginsenoside R1 with sodium glycocholate-mediated liposomes: Preparation by supercritical fluid technology and evaluation in vitro and in vivo.
Fan Q; Zhang Y; Hou X; Li Z; Zhang K; Shao Q; Feng N
Int J Pharm; 2018 Dec; 552(1-2):360-370. PubMed ID: 30292894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]